KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Other Non-Current Assets (2016 - 2019)

Pacira BioSciences has reported Other Non-Current Assets over the past 10 years, most recently at $560000.0 for Q1 2019.

  • Quarterly results put Other Non-Current Assets at $560000.0 for Q1 2019, down 26.22% from a year ago — trailing twelve months through Mar 2019 was $560000.0 (down 26.22% YoY), and the annual figure for FY2018 was $657000.0, down 20.36%.
  • Other Non-Current Assets for Q1 2019 was $560000.0 at Pacira BioSciences, down from $657000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for PCRX hit a ceiling of $2.6 million in Q3 2015 and a floor of $406000.0 in Q4 2015.
  • Median Other Non-Current Assets over the past 5 years was $657000.0 (2018), compared with a mean of $945470.6.
  • Biggest five-year swings in Other Non-Current Assets: plummeted 84.31% in 2015 and later surged 53.69% in 2016.
  • Pacira BioSciences' Other Non-Current Assets stood at $406000.0 in 2015, then skyrocketed by 53.69% to $624000.0 in 2016, then surged by 32.21% to $825000.0 in 2017, then fell by 20.36% to $657000.0 in 2018, then fell by 14.76% to $560000.0 in 2019.
  • The last three reported values for Other Non-Current Assets were $560000.0 (Q1 2019), $657000.0 (Q4 2018), and $747000.0 (Q3 2018) per Business Quant data.